Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
The global Botulinum Toxin Type A market is projected to grow from US$ 6820 million in 2024 to US$ 8335.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
In terms of production side, this report researches the Botulinum Toxin Type A production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Botulinum Toxin Type A by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Botulinum Toxin Type A, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Botulinum Toxin Type A, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Botulinum Toxin Type A, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Botulinum Toxin Type A sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Botulinum Toxin Type A market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Botulinum Toxin Type A sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
Segment by Type
50 Units
100 Units
200 Units
Segment by Application
Cosmetic Applications
Therapeutic Applications
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Botulinum Toxin Type A production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Botulinum Toxin Type A in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Botulinum Toxin Type A manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botulinum Toxin Type A sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Botulinum Toxin Type A Product Introduction
1.2 Market by Type
1.2.1 Global Botulinum Toxin Type A Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 50 Units
1.2.3 100 Units
1.2.4 200 Units
1.3 Market by Application
1.3.1 Global Botulinum Toxin Type A Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Cosmetic Applications
1.3.3 Therapeutic Applications
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Botulinum Toxin Type A Production
2.1 Global Botulinum Toxin Type A Production Capacity (2019-2030)
2.2 Global Botulinum Toxin Type A Production by Region: 2019 VS 2023 VS 2030
2.3 Global Botulinum Toxin Type A Production by Region
2.3.1 Global Botulinum Toxin Type A Historic Production by Region (2019-2024)
2.3.2 Global Botulinum Toxin Type A Forecasted Production by Region (2025-2030)
2.3.3 Global Botulinum Toxin Type A Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Botulinum Toxin Type A Revenue Estimates and Forecasts 2019-2030
3.2 Global Botulinum Toxin Type A Revenue by Region
3.2.1 Global Botulinum Toxin Type A Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Botulinum Toxin Type A Revenue by Region (2019-2024)
3.2.3 Global Botulinum Toxin Type A Revenue by Region (2025-2030)
3.2.4 Global Botulinum Toxin Type A Revenue Market Share by Region (2019-2030)
3.3 Global Botulinum Toxin Type A Sales Estimates and Forecasts 2019-2030
3.4 Global Botulinum Toxin Type A Sales by Region
3.4.1 Global Botulinum Toxin Type A Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Botulinum Toxin Type A Sales by Region (2019-2024)
3.4.3 Global Botulinum Toxin Type A Sales by Region (2025-2030)
3.4.4 Global Botulinum Toxin Type A Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Botulinum Toxin Type A Sales by Manufacturers
4.1.1 Global Botulinum Toxin Type A Sales by Manufacturers (2019-2024)
4.1.2 Global Botulinum Toxin Type A Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Botulinum Toxin Type A in 2023
4.2 Global Botulinum Toxin Type A Revenue by Manufacturers
4.2.1 Global Botulinum Toxin Type A Revenue by Manufacturers (2019-2024)
4.2.2 Global Botulinum Toxin Type A Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Botulinum Toxin Type A Revenue in 2023
4.3 Global Botulinum Toxin Type A Sales Price by Manufacturers
4.4 Global Key Players of Botulinum Toxin Type A, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Botulinum Toxin Type A Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Botulinum Toxin Type A, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Botulinum Toxin Type A, Product Offered and Application
4.8 Global Key Manufacturers of Botulinum Toxin Type A, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Botulinum Toxin Type A Sales by Type
5.1.1 Global Botulinum Toxin Type A Historical Sales by Type (2019-2024)
5.1.2 Global Botulinum Toxin Type A Forecasted Sales by Type (2025-2030)
5.1.3 Global Botulinum Toxin Type A Sales Market Share by Type (2019-2030)
5.2 Global Botulinum Toxin Type A Revenue by Type
5.2.1 Global Botulinum Toxin Type A Historical Revenue by Type (2019-2024)
5.2.2 Global Botulinum Toxin Type A Forecasted Revenue by Type (2025-2030)
5.2.3 Global Botulinum Toxin Type A Revenue Market Share by Type (2019-2030)
5.3 Global Botulinum Toxin Type A Price by Type
5.3.1 Global Botulinum Toxin Type A Price by Type (2019-2024)
5.3.2 Global Botulinum Toxin Type A Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Botulinum Toxin Type A Sales by Application
6.1.1 Global Botulinum Toxin Type A Historical Sales by Application (2019-2024)
6.1.2 Global Botulinum Toxin Type A Forecasted Sales by Application (2025-2030)
6.1.3 Global Botulinum Toxin Type A Sales Market Share by Application (2019-2030)
6.2 Global Botulinum Toxin Type A Revenue by Application
6.2.1 Global Botulinum Toxin Type A Historical Revenue by Application (2019-2024)
6.2.2 Global Botulinum Toxin Type A Forecasted Revenue by Application (2025-2030)
6.2.3 Global Botulinum Toxin Type A Revenue Market Share by Application (2019-2030)
6.3 Global Botulinum Toxin Type A Price by Application
6.3.1 Global Botulinum Toxin Type A Price by Application (2019-2024)
6.3.2 Global Botulinum Toxin Type A Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Botulinum Toxin Type A Market Size by Type
7.1.1 US & Canada Botulinum Toxin Type A Sales by Type (2019-2030)
7.1.2 US & Canada Botulinum Toxin Type A Revenue by Type (2019-2030)
7.2 US & Canada Botulinum Toxin Type A Market Size by Application
7.2.1 US & Canada Botulinum Toxin Type A Sales by Application (2019-2030)
7.2.2 US & Canada Botulinum Toxin Type A Revenue by Application (2019-2030)
7.3 US & Canada Botulinum Toxin Type A Sales by Country
7.3.1 US & Canada Botulinum Toxin Type A Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Botulinum Toxin Type A Sales by Country (2019-2030)
7.3.3 US & Canada Botulinum Toxin Type A Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Botulinum Toxin Type A Market Size by Type
8.1.1 Europe Botulinum Toxin Type A Sales by Type (2019-2030)
8.1.2 Europe Botulinum Toxin Type A Revenue by Type (2019-2030)
8.2 Europe Botulinum Toxin Type A Market Size by Application
8.2.1 Europe Botulinum Toxin Type A Sales by Application (2019-2030)
8.2.2 Europe Botulinum Toxin Type A Revenue by Application (2019-2030)
8.3 Europe Botulinum Toxin Type A Sales by Country
8.3.1 Europe Botulinum Toxin Type A Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Botulinum Toxin Type A Sales by Country (2019-2030)
8.3.3 Europe Botulinum Toxin Type A Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Botulinum Toxin Type A Market Size by Type
9.1.1 China Botulinum Toxin Type A Sales by Type (2019-2030)
9.1.2 China Botulinum Toxin Type A Revenue by Type (2019-2030)
9.2 China Botulinum Toxin Type A Market Size by Application
9.2.1 China Botulinum Toxin Type A Sales by Application (2019-2030)
9.2.2 China Botulinum Toxin Type A Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Botulinum Toxin Type A Market Size by Type
10.1.1 Asia Botulinum Toxin Type A Sales by Type (2019-2030)
10.1.2 Asia Botulinum Toxin Type A Revenue by Type (2019-2030)
10.2 Asia Botulinum Toxin Type A Market Size by Application
10.2.1 Asia Botulinum Toxin Type A Sales by Application (2019-2030)
10.2.2 Asia Botulinum Toxin Type A Revenue by Application (2019-2030)
10.3 Asia Botulinum Toxin Type A Sales by Region
10.3.1 Asia Botulinum Toxin Type A Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Botulinum Toxin Type A Revenue by Region (2019-2030)
10.3.3 Asia Botulinum Toxin Type A Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Botulinum Toxin Type A Market Size by Type
11.1.1 Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Botulinum Toxin Type A Market Size by Application
11.2.1 Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Country
11.3.1 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Botulinum Toxin Type A Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Botulinum Toxin Type A Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 ALLERGAN
12.1.1 ALLERGAN Company Information
12.1.2 ALLERGAN Overview
12.1.3 ALLERGAN Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 ALLERGAN Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 ALLERGAN Recent Developments
12.2 Galderma
12.2.1 Galderma Company Information
12.2.2 Galderma Overview
12.2.3 Galderma Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Galderma Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Galderma Recent Developments
12.3 Merz Pharma
12.3.1 Merz Pharma Company Information
12.3.2 Merz Pharma Overview
12.3.3 Merz Pharma Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Merz Pharma Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Merz Pharma Recent Developments
12.4 DAEWOONG
12.4.1 DAEWOONG Company Information
12.4.2 DAEWOONG Overview
12.4.3 DAEWOONG Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 DAEWOONG Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 DAEWOONG Recent Developments
12.5 Ipsen
12.5.1 Ipsen Company Information
12.5.2 Ipsen Overview
12.5.3 Ipsen Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Ipsen Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Ipsen Recent Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Overview
12.6.3 Pfizer Botulinum Toxin Type A Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Pfizer Botulinum Toxin Type A Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Pfizer Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Botulinum Toxin Type A Industry Chain Analysis
13.2 Botulinum Toxin Type A Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Botulinum Toxin Type A Production Mode & Process
13.4 Botulinum Toxin Type A Sales and Marketing
13.4.1 Botulinum Toxin Type A Sales Channels
13.4.2 Botulinum Toxin Type A Distributors
13.5 Botulinum Toxin Type A Customers
14 Botulinum Toxin Type A Market Dynamics
14.1 Botulinum Toxin Type A Industry Trends
14.2 Botulinum Toxin Type A Market Drivers
14.3 Botulinum Toxin Type A Market Challenges
14.4 Botulinum Toxin Type A Market Restraints
15 Key Finding in The Global Botulinum Toxin Type A Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
听
听
*If Applicable.
